Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.5.0.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Cash Flows From Operating Activities    
Net loss $ (14,613,000) $ (15,741,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 3,490,000 3,775,000
Realignment accrual accretion 29,000 104,000
Interest accretion 1,601,000 825,000
Provision for bad debt 482,000 202,000
Gain on sale of discontinued operations (217,000)
Stock-based compensation 109,000 1,517,000
Asset impairment 3,363,000
Change in fair value of contingent consideration (1,174,000)
Deferred taxes (634,000)
Other (gains), losses and expenses, net (4,000)
Other changes in assets and liabilities:    
Decrease (increase) in accounts receivable 4,639,000 (4,257,000)
Decrease in unbilled receivable 16,000 702,000
Decrease in other current assets 1,272,000 1,084,000
Decrease in other long-term assets 754,000 2,137,000
(Decrease) increase in accounts payable (761,000) 200,000
(Decrease) increase in unearned contract revenue (11,000) 396,000
(Decrease) increase in accrued salaries and bonus (685,000) 2,155,000
Decrease in accrued liabilities (4,561,000) (7,318,000)
(Decrease) increase in long-term liabilities (563,000) 1,534,000
Net cash used in operating activities (6,617,000) (13,536,000)
Cash Flows From Investing Activities    
Purchase of property and equipment (583,000)
Net cash used in investing activities (583,000)
Cash Flows From Financing Activities    
Cash paid for repurchase of restricted shares (37,000)
Net cash used in financing activities (37,000)
Net increase (decrease) in cash and cash equivalents (6,617,000) (14,156,000)
Cash and cash equivalents – beginning 8,310,000 23,111,000
Cash and cash equivalents – ending 1,693,000 8,955,000
Cash paid for interest $ 2,153,000